X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Asia

Amcor Healthcare Packaging Expansion in Asia Pacific

API PA by API PA
16th April 2025
in Asia, News, Packaging & Logistic
Healthcare Packaging

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

A global pioneer in creating and manufacturing responsible packaging solutions, has finished building its advanced coating plant for healthcare packaging in Selangor, Malaysia. Strengthening the supply of high-quality, sterile packaging for healthcare consumers across the region, this state-of-the-art plant is the first in Asia to use innovative air knife coating technology.

This development is a key milestone in the Amcor healthcare packaging expansion, as the new facility builds on its current healthcare packaging factory in Selangor to form an integrated campus making Amcor the first in Asia to manufacture both top and bottom substrates for medical device packaging.  This advancement offers important advantages to consumers, such improved supply chain resilience and shorter lead times.

As a central part of the Amcor healthcare packaging expansion, the facility sets new norms for precision and efficiency equipped with innovative technologies including water-based coating systems, online inspection systems and air knife technology.  Particularly the air knife technique guarantees consistent coating application by means of high-speed air streams, hence improving product uniformity and lowering material waste.

“Amcor’s investment in this new facility reflects our unwavering commitment to support our customers across the Asia Pacific region,” said Chris Kenneally, president of Amcor Flexibles Asia Pacific. “By introducing advanced coating technology and boosting local production capacity, we are better positioned to meet the growing regional demand for sterile, reliable packaging and to offer our customers greater flexibility and security.”

“Producing our industry-leading global product platform locally brings us closer to our customers, enhancing supply security and flexibility,” said Virginie Maes, vice president of global healthcare, Amcor. “By investing in advanced coating technologies and expanding our regional capabilities, we are not only addressing the growing demand for high-performance healthcare packaging but also reinforcing our promise to deliver a consistent and innovative value proposition to our customers worldwide.”

Amcor healthcare packaging expansion is dedicated to increase its healthcare capacity in the Asia Pacific area includes this new facility. Recent projects include the building of a co-extrusion blown film and printing plant in Singapore, the creation of a grid lacquer paper unit in India, and the purchase of healthcare packaging business MDK in China.

Tags: Asia Pacific
Previous Post

AstraZeneca Eyes Acquisition To Develop Cell Therapies

Next Post

Asia Pacific Omics-Based Clinical Trials Market Growth

Related Posts

ChiRhoClin LogiCare3PL Partners for Drug Distribution
News

ChiRhoClin, LogiCare3PL Partners for Drug Distribution

21st July 2025
Thermo Fisher and Sanofi Partners
Manufacturing

Thermo Fisher and Sanofi Partners for US Drug Manufacturing

21st July 2025
EMA Recommendations to Secure Anti D Immunoglobulins Supply
News

EMA Recommendations to Secure Anti-D Immunoglobulins Supply

15th July 2025
FDA Approves Oral Therapy for Treating Hereditary Angioedema
FDA Approvals

FDA Approves Oral Therapy for Treating Hereditary Angioedema

15th July 2025
WuXi Biologics and Virogen Bio partner to advance VG712
News

WuXi Biologics and Virogen Bio partner to advance VG712

19th June 2025
Construction of WuXi Biologics Microbial Manufacturing Site
News

Construction of WuXi Biologics Microbial Manufacturing Site

19th June 2025
Next Post
Omics Based Clinical Trials

Asia Pacific Omics-Based Clinical Trials Market Growth

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In